Companies House · 01729064

DR REDDY'S LABORATORIES (UK) LIMITED

UK registered company, private limited company, incorporated 3 Jun 1983.

Active
50
Public contracts
0
Spend payments
Total spend

DR REDDY'S LABORATORIES (UK) LIMITED is a UK company registered at Companies House under number 01729064. This page links its registry record to its activity in UK public procurement — the contracts it has been awarded and the transparency-spend payments recorded against it.

Companies House record

Company number
01729064
Status
Active
Company type
Private Limited Company
Incorporated
3 Jun 1983
Country of origin
United Kingdom
Registered office
410 CAMBRIDGE SCIENCE PARK, CAMBRIDGE, CB4 0PE, ENGLAND
Nature of business (SIC)
21200 - Manufacture of pharmaceutical preparations
Accounts category
FULL
View source on data.gov.uk

Public sector contracts

Contract awards linked to DR REDDY'S LABORATORIES (UK) LIMITED.

ProcurementBuyerAwardedValue
NHS National Transition Framework for Apremilast, Pazopanib and DapagliflozinNHS England
NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025NHS England
Proprietary DrugseTenderwales
NHS National Pharmaceuticals - Everolimus and terminated agreement productsThe NHS Commissioning Board (operating under the name of NHS England)
NHS National Pharmaceuticals - Everolimus and terminated agreement productsThe NHS Commissioning Board (operating under the name of NHS England)
NHS National Pharmaceuticals - Everolimus and terminated agreement productsThe NHS Commissioning Board (operating under the name of NHS England)
NHS National Generic Pharmaceuticals Transition 2021_1The NHS Commissioning Board (operating under the name of NHS England)
NHS National Generic Pharmaceuticals Transition 2021_1The NHS Commissioning Board (operating under the name of NHS England)
NHS National Framework for the supply of Generics Housekeeping / Supply Chain Resilience Products, commencing 1 June 2025NHS England
NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) for the treatment of HIV (Lot 1) 1 Nov 2024NHS England
NHS National Framework for Transition products commencing 1 October 2024NHS England
NHS Branded Medicines Tranche Framework for London and South of England - 1 September 2024NHS England
NHS Branded Medicines Tranche Framework for London and South of England - 1 September 2024NHS England
Generic Drugs - Tablets & CapsulesVelindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services ( on behalf of All LHB's and Trusts )
Transitional Drugs 2Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales UHBs & Trusts
NHS National Framework for Transition Products (Nintedanib and Dalbavancin)NHS England
NHS National Framework for Transition Products (Nintedanib and Dalbavancin)NHS England25 Feb 2026£14.8m
NHS National Transition Framework for Apremilast, Pazopanib and DapagliflozinNHS England25 Nov 2025£25.9m
NHS National Framework for Transition products (Axitinib and Eltrombopag)NHS England15 Jul 2025£52.4m
NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025NHS England30 Jun 2025£986.3m
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza NationalNHS England24 Jun 2025£261.9m
NHS National Framework for Transition products (Nilotinib and Ticagrelor)NHS England North East & Yorkshire11 Jun 2025£22.1m
NHS National Framework for Transition products (Nilotinib and Ticagrelor)NHS England North East & Yorkshire11 Jun 2025£22.1m
NHS National Framework - Generics Housekeeping/Supply Chain Resilience ProductsNHS England15 Apr 2025£11.7m
CM/TNS/24/5713 - NHS Framework for Transition products - 1 February 2025NHS England14 Jan 2025£9.9m
NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024NHS England28 Oct 2024£626.5m
NHS National Framework for Transition products commencing 1 October 2024NHS England29 Sept 2024£16.2m
NHS Branded Medicines Tranche Framework for London and South of EnglandNHS England21 Jul 2024£381m
NHS National Framework for Transition products commencing 1 May 2024NHS ENGLAND15 Apr 2024£7.6m
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)NHS England4 Mar 2024£1
NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024NHS England26 Jan 2024£688m
CM/PHR/22/5687 - NHS National Proprietary Low Molecular Weight HeparinsNHS England13 Jul 2023£186.6m
NHS National Generic Pharmaceuticals Wave 14bATAMIS LTD6 Jul 2023£428.2m
NHS National Generics Pharmaceuticals Transition 2023_1NHS england4 May 2023£57.6m
NHS National Generic Pharmaceuticals Wave 14aNHS England14 Dec 2022£208m
NHS National Pharmaceuticals Transition 2022_2NHS England1 Nov 2022£35.7m
NHS National Pharmaceuticals Transition 2022_1NHS England and NHS Improvement18 Jul 2022£39.6m
NHS National Pharmaceuticals Transition 2022_1NHS England and NHS Improvement18 Jul 2022£39.6m
National Procurement for HIV and Preventative TreatmentsNHSE&I1 Feb 2022£230m
NHS National Generic Pharmaceuticals Wave 13ATAMIS LTD30 Nov 2021£469.7m
NHS National Generic Pharmaceuticals Wave 13ATAMIS LTD30 Nov 2021£469.7m
NHS National Generic Pharmaceuticals Wave 13ATAMIS LTD30 Nov 2021£469.7m
NHS National Pharmaceuticals Transition 2021_3NHS England21 Oct 2021£26m
NHS Framework Agreement, Branded Medicines for London and South of EnglandNHS England18 Aug 2021£558.5m
NHS Framework Agreement, Branded Medicines for London and South of EnglandNHS England18 Aug 2021£558.5m
NHS National Pharmaceuticals - Everolimus and terminated agreement productsNHS England7 Jun 2021£4.5m
NHS National Generic Pharmaceuticals - Transition 2021_2NHS England31 Mar 2021£2.8m
NHS National Generic Pharmaceuticals- Transition 2021_1NHS England3 Mar 2021£8.9m
NHS Framework for the Midlands and East, Branded Medicines - Tranche BNHS England25 Jan 2021£228.2m
NHS National Pharmaceuticals - Fulvestrant, Darunavir and ImatinibNHS England4 Jan 2021£17.3m

Supplier identities

How this company appears as a supplier across the data.

FAQs about DR REDDY'S LABORATORIES (UK) LIMITED

Is DR REDDY'S LABORATORIES (UK) LIMITED an active company?

DR REDDY'S LABORATORIES (UK) LIMITED (company number 01729064) is recorded as "Active", incorporated on 3 Jun 1983.

What does DR REDDY'S LABORATORIES (UK) LIMITED do?

Its Companies House nature-of-business (SIC) is: 21200 - Manufacture of pharmaceutical preparations.

Has DR REDDY'S LABORATORIES (UK) LIMITED won UK public-sector contracts?

Yes — 50 public-sector contract awards are linked to this company in our data.

Where is DR REDDY'S LABORATORIES (UK) LIMITED based?

Its registered office is 410 CAMBRIDGE SCIENCE PARK, CAMBRIDGE, CB4 0PE, ENGLAND.

Understand any company's public-sector footprint

Enable links Companies House to live procurement and spend data — see contracts, buyers and payments for any UK supplier.

Get in touch with Enable